Raptiva

Bold labels are required.

Contact Information

Name

E-mail Address Please enter a valid e-mail address.

Phone

Address

Brief description of your legal issue

Please verify that you have read the disclaimer. I have read the disclaimer. disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

RAPTIVA® PERSONAL INJURY ATTORNEY

Raptiva (efalizumab), is a drug prescribed to treat individuals with Psoriasis. In October of 2008, the United States Food & Drug Administration (FDA) required the manufacturer, Genentech Inc, to place a "black box" warning on Raptiva concerning the risk of progressive multifocal leukoencephalopathy "PML," bacterial sepsis, viral meningitis, invasive fungal disease and other infections. Since the black box warning, Genentech has pulled Raptiva from the market and will no longer be sold in the United States.

Serious Side-Effects

If you or a loved one have used Raptiva and been diagnosed with PML, bacterial sepsis, viral meningitis, or other infections you may be entitled to compensation for your injuries.

Our attorneys are here to help you obtain compensation for your injuries due to Raptiva use. Please contact us today for a Free evaluation by calling James F. Humphreys & Associates, L.C. 1-877-341-2595 or by completing our online form.